FIELD: medicine.
SUBSTANCE: invention is related to compound of formula (I), 
(values of radicals are described in formula of invention) or its pharmaceutically acceptable salts, to methods of its production, pharmaceutical composition, which contains it. Application of invention is described for manufacturing of medicinal agent intended for provision of inhibiting action in respect to HDAC in warm-blooded animal, in production of agent used for treatment of malignant tumor. Method is also described for provision of inhibiting action in warm-blooded animal.
EFFECT: compounds have inhibiting activity in respect to HDAC.
15 cl, 17 tbl, 24 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATIONS WHICH INCLUDE RECEPTOR S1P AGONIST AND JAK3 KINASE INHIBITOR | 2005 |
|
RU2415678C2 |
| DERIVATIVES OF 4-ANILINO-BENZODIAZINE, METHOD OF OBTAINING THEM (VERSIONS) PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITING THEIR PROLIFERATIVE ACTION AND METHOD OF TREATING CANCER IN WARM-BLOODED ANIMAL | 2003 |
|
RU2345989C2 |
| HYDROXYLATED AND METHOXYLATED CYCLOPENTA[B]PYRIMIDINES AS PROTEIN KINASE INHIBITORS | 2007 |
|
RU2478632C2 |
| PYRIDYLALKENE AND PYRIDYLALKYNE ACID AMIDES, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF ITS PREPARING | 1997 |
|
RU2200734C2 |
| SYNTHETIC METHOD OF REDUCING ALKYLATING OF INDOLES IN C-3-POSITION | 2004 |
|
RU2352560C2 |
| DERIVATIVES OF PYRIMIDINE, METHOD FOR THEIR PREPARING (VARIANTS), PHARMACEUTICAL COMPOSITIONS (VARIANTS) AND INHIBITION METHOD | 2001 |
|
RU2299201C2 |
| DERIVATIVES OF PYRAZIOLE WITH CONDENSED CYCLE | 2002 |
|
RU2318822C2 |
| IMIDAZO[1,2-A]PYRIDINE AND PYRAZOLE[2,3-A]PYRIDINE DERIVATIVES | 2000 |
|
RU2248976C2 |
| OBTAINING DIHYDROTHIENO[3,2-d]PYRIMIDINES AND INTERMEDIATE PRODUCTS, APPLIED FOR THEIR SYNTHESIS | 2008 |
|
RU2528340C2 |
| 2,5,7-SUBSTITUTED OXAZOLPYRIMIDINE DERIVATIVES | 2011 |
|
RU2557246C2 |
